Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 12.8
Adjusted Graft Survival, Deceased Donor Lung Transplants
Survival at 3 Months, 1 Year, 5 Years, and 10 Years
3 Months
1 Year
5 Years
10 Years
(Tx 2007 - 2008)
(Tx 2007 - 2008)
(Tx 2003 - 2008)
(Tx 1998 - 2008)
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
Total
All
2,931
91.7%
0.5%
2,931
81.7%
0.7%
7,948
50.6%
0.8%
12,650
24.6%
0.8%
Primary Diagnosis
Emphysema/COPD
840
92.5%
0.9%
840
83.1%
1.3%
2,581
53.4%
1.3%
4,585
22.7%
1.2%
Cystic Fibrosis
415
93.6%
1.5%
415
79.8%
2.8%
1,211
48.2%
2.3%
1,967
29.3%
1.9%
Idiopathic Pulmonary Fibrosis
979
92.0%
0.9%
979
82.2%
1.3%
2,279
49.7%
1.5%
3,075
23.4%
1.8%
Alpha-1-Antitrypsin Deficiency
84
97.7%
1.6%
84
90.7%
3.1%
314
59.5%
3.2%
684
24.9%
2.9%
Idiopathic Pulmonary Arterial Hypertension
53
84.5%
5.3%
53
80.1%
5.9%
203
46.3%
4.5%
410
33.1%
3.3%
Congenital Disease
5
100.0%
0.0%
5
74.5%
18.9%
24
31.8%
10.2%
89
30.5%
5.8%
Other
553
88.4%
1.4%
553
79.0%
1.8%
1,334
50.9%
1.9%
1,837
31.2%
2.0%
Unknown
2
39.1%
22.6%
2
39.1%
22.6%
2
51.8%
24.6%
3
69.7%
20.8%
Source: OPTN/SRTR Data as of October 1, 2010.
(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.
Cohorts are transplants performed during the years listed at the top of the table.
Graft survival follows individual transplants until graft failure.
Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.
Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.
Multi-organ transplants are excluded.
Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.